Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

The purpose of this study is to determine the feasibility of routine referral to genetic counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or fallopian tube cancer.

Inclusion Criteria:

• All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal, fallopian tube or extra- uterine mullerian cancer.
• All subjects must have either undergone primary surgery or be planning neoadjuvant chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube cancer.
• All subjects must be able to comprehend and communicate in English.
• All subjects must agree to participate.
• A previous diagnosis of cancer is not an exclusion criterion.
• Previous genetic screening is not an exclusion criterion.

Exclusion Criteria:

• Patients who do not meet the above inclusion criteria.
• Patients with a diagnosis of a low malignant potential mullerian tumor.
• Patients who are not proficient in English language because the survey aspect of this study is comprised of 4 validated surveys that are only available in English language.